penbutolol has been researched along with atenolol in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hashimoto, K; Hauswirth, O; Wehner, HD; Ziskoven, R | 1 |
| Pala, AM; Ricciardelli, D; Sanna, A; Vinattieri, MA | 1 |
| Desager, JP; Harvengt, C; Heller, F; Hulhoven, R | 1 |
| Fallo, F; Mantero, F; Pisani, G | 1 |
| Bianchini, C; Gennari, C; Martinelli, M; Nami, R | 1 |
| Harno, K; Maass, L; Nikkilä, EA; Välimäki, M | 1 |
| Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
| Kirch, W; Mutschler, E; Spahn, H | 2 |
| Houtzagers, JJ; Lameijer, LD; Voermans, LA | 1 |
| Kuhn, S; Mucklow, JC | 1 |
| Chadha, DR; Houtzagers, JJ; Lameijer, LD; Voermans, LA | 1 |
| Chadha, DR; Houtzagers, JJ | 1 |
1 review(s) available for penbutolol and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for penbutolol and atenolol
| Article | Year |
|---|---|
[The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrocardiography; Female; Humans; Hypertension; Middle Aged; Penbutolol; Randomized Controlled Trials as Topic; Regression Analysis | 1989 |
[Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
Topics: Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines; Random Allocation | 1988 |
Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.
Topics: Adult; Apoproteins; Atenolol; Blood Pressure; Body Weight; Cholesterol, HDL; Heart Rate; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Penbutolol; Propanolamines; Time Factors; Triglycerides | 1986 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
A comparative study of atenolol and penbutolol in hypertensive patients.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Diastole; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines; Pulse; Systole | 1983 |
The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Delayed-Action Preparations; Heart Rate; Humans; Male; Maximal Expiratory Flow Rate; Metoprolol; Middle Aged; Penbutolol; Propanolamines | 1984 |
Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Penbutolol; Physical Exertion; Propanolamines; Pulse; Random Allocation | 1981 |
Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
Topics: Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Metoprolol; Penbutolol; Propanolamines; Propranolol; Pulse | 1982 |
10 other study(ies) available for penbutolol and atenolol
| Article | Year |
|---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
The relation between the current underlying pacemaker activity and beta-adrenoceptors in cardiac Purkinje fibres: a study using adrenaline, procaine, atenolol and penbutolol.
Topics: Animals; Atenolol; Epinephrine; Heart Conduction System; In Vitro Techniques; Isomerism; Kinetics; Membrane Potentials; Penbutolol; Procaine; Propanolamines; Purkinje Fibers; Receptors, Adrenergic; Receptors, Adrenergic, beta; Sheep | 1979 |
Beta-blocking agents and plasma lipids: an update.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Atenolol; Cholesterol, LDL; Coronary Disease; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, LDL; Oxprenolol; Penbutolol; Pindolol; Sotalol | 1987 |
[Comparative study of penbutolol and atenolol in the therapy of essential hypertension].
Topics: Adult; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines | 1988 |
The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Cimetidine; Drug Interactions; Histamine H2 Antagonists; Humans; Kinetics; Metoprolol; Penbutolol; Pindolol; Propranolol; Ranitidine | 1984 |
The interaction of cimetidine with metoprolol, atenolol, propranolol, pindolol and penbutolol.
Topics: Atenolol; Biological Availability; Cimetidine; Drug Interactions; Guanidines; Humans; Metoprolol; Penbutolol; Pindolol; Propanolamines; Propranolol | 1983 |